Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Ghko B 2026 Mar 12, 16:01

Adani Total Gas stock (ATGL) surged 37% in two days: What's going on with gas prices?

Ghko B 2026 Mar 12, 16:01

Starbucks (SBUX) shares analysis: Is Starbucks a good stock to buy right now?

Ghko B 2026 Mar 12, 16:01

Will Nvidia (NVDA) stock hit $300: What is the NVDA price prediction for 2030?

Frances Wang 2026 Mar 12, 16:01

SES AI Corp stock analysis: Why SES stock is trading down today?

Ghko B 2026 Mar 12, 16:01

How to buy the top AI stocks in the Emirates: Microsoft (MSFT), Nvidia (NVDA), Alphabet stock

Ghko B 2026 Mar 11, 16:02

The Vanguard S&P 500 ETF is popular: Is VOO a good ETF to invest in?

Frances Wang 2026 Mar 11, 16:01

Forex Market Analysis: JPY/USD, CHF/USD, EUR/USD, GBP/USD

Ghko B 2026 Mar 11, 16:01

Most active stocks analysis: NVIDIA (NVDA), Tesla (TSLA), Amazon (AMZN) stock

Ghko B 2026 Mar 11, 16:01

A beginner's guide to investing in stocks: How to buy NVDA stock in United Arab Emirates?

Frances Wang 2026 Mar 10, 16:01

Commodity market today: UAE gold prices swing, what factors affect the price of gold?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

2.28

Spread (%)

0.6241 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

198263701504

Shares Outstanding

539067675

Earnings Date (Next)

1999-11-22

Div Yield

2026-06-05

Ex-Dividend Date

2026-05-15

Forward annual dividend rate

10.08

Forward annual dividend yield

0.0267

EPS

14.24

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Mar 11, 16:01

Gold prices today in the UAE: How to begin investing in gold in the UAE?

Ghko B 2026 Mar 02, 16:00

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B 2026 Mar 01, 16:00

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Trustpilot